Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ ob mice

Journal of Physiology

Volumn 587, Issue 7, 2009, Pages 1593-1605

  Turpin, S M ^a   Ryall, J G ^a   Southgate, R ^c   Darby, I ^d   Hevener, A L ^e   Febbraio, M A ^f   Kemp, B E ^a   Lynch, G S ^a   Watt, Matthew J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d RMIT UNIVERSITY   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; CASPASE 3; FATTY ACID; PROTEIN BCL 2; LIGHT CHAIN 3 ALPHA; LIGHT CHAIN 3 BETA; MYOSIN ADENOSINE TRIPHOSPHATASE; PEPTIDES AND PROTEINS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; LIPID ANALYSIS; LIPID DIET; LIPID STORAGE; MALE; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; ANIMAL MODEL; DNA FRAGMENTATION; DOWN REGULATION; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; LIPID COMPOSITION; LIPOTOXICITY; MUSCLE MASS; PROTEIN CONTENT; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CASPASE 3; DIETARY FATS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION PROFILING; HYPERTROPHY; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 63849125553     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.166033     Document Type: Article

References (52)

1. Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC & Mandarino LJ (2004). Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53, 25-31.
2. Almond RE & Enser M (1984). A histochemical and morphological study of skeletal muscle from obese hyperglycaemic ob/ob mice. Diabetologia 27, 407-413.
3. Baron AD, Brechtel G, Wallace P & Edelman SV (1988). Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol Endocrinol Metab 255, E769-774.
4. Bassel-Duby R & Olson EN (2006). Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75, 19-37.
5. Bickerton AS, Roberts R, Fielding BA, Tornqvist H, Blaak EE, Wagenmakers AJ, Gilbert M, Humphreys SM, Karpe F & Frayn KN (2008). Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51, 1466-1474.
6. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ & Dyck DJ (2004). Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18, 1144-1146.
7. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H & Rieusset J (2008). Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118, 789-800.
8. Boya P, Gonzalez-Polo R-A, Casares N, Perfettini J-L, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P & Kroemer G (2005). Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25, 1025-1040.
9. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, Nelson DA, Jin S & White E (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64.
10. Ding W-X, Ni H-M, Gao W, Yoshimori T, Stolz DB, Ron D & Yin X-M (2007). Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 171, 513-524.
11. Dominguez LJ & Barbagallo M (2007). The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr 2, 183-189.
12. Findlay D, Raggatt L, Bouralexis S, Hay S, Atkins G & Evdokiou A (2002). Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. J Endocrinol 175, 715-725.
13. Fluck M & Hoppeler H (2003). Molecular basis of skeletal muscle plasticity: From gene to form and function. Rev Physiol Biochem Pharmacol 146, 159-216.
14. Furuyama T, Kitayama K, Yamashita H & Mori N (2003). Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J 375, 365-371.
15. Garris D (2005). Cytochemical analysis of pancreatic islet lipoapoptosis: Hyperlipidemia-induced cytoinvolution following expression of the diabetes (db/db) mutation. Pathobiology 72, 124-123.
16. Ghosh S, An D, Pulinilkunnil T, Qi D, Lau HC, Abrahani A, Innis SM & Rodrigues B (2004). Role of dietary fatty acids and acute hyperglycemia in modulating cardiac cell death. Nutrition 20, 916-923.
17. Goldspink D, Garlick P & McNurlan MA (1983). Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem J 210, 89-98.
18. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G & Zechner R (2006). Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737.
19. Hamalainen N & Pette D (1993). The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit. J Histochem Cytochem 41, 733-743.
20. Holloszy JO (1967). Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242, 2278-2282.
21. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G & Klein S (1999). Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol Endocrinol Metab 276, E278-284.
22. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, MacDonald KG & Shulman GI (2002). Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51, 2959-2963.
23. Jagoe R & Goldberg A (2001). What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 4, 183-190.
24. Lee SD, Tzang BS, Kuo WW, Lin YM, Yang AL, Chen SH, Tsai FJ, Wu FL, Lu MC & Huang CY (2007). Cardiac fas receptor-dependent apoptotic pathway in obese Zucker rats. Obesity (Silver Spring) 15, 2407-2415.
25. Lee SW, Dai G, Hu Z, Wang X, Du J & Mitch WE (2004). Regulation of muscle protein degradation: Coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15, 1537-1545.
26. Lillioja S, Young A, Culter C, Ivy L, Abbott W, Zawadzki J, Yki-Jarvinen H, Chnstin L, Secomb T & Bogardus C (1987). Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80, 415-424.
27. Lin J, Wu H, Tarr PT, Zhang C-Y, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R & Spiegelman BM (2002). Transcriptional co-activator PGC-1a drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
28. Maiuri MC, Zalckvar E, Kimchi A & Kroemer G (2007). Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8, 741-752.
29. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S & Sandri M (2007). FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metabolism 6, 458-471.
30. Minnaard R, Drost M, Wagenmakers A, van Kranenburg G, Kuipers H & Hesselink MKC (2005). Skeletal muscle wasting and contractile performance in septic rats. Muscle Nerve 31, 339-348.
31. Ozcan U, Hotamisligil GS & Cao Q (2004). Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461.
32. Pattingre S, Espert L, Biard-Piechaczyk M & Codogno P (2008). Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323.
33. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD & Levine B (2005). Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 122, 927-939.
34. Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE & Bell RM (1986). Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem 261, 8597-8600.
35. Ryall JG, Gregorevic P, Plant DR, Sillence MN & Lynch GS (2002). β2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. Am J Physiol Regul Integr Comp Physiol 283, R1386-1394.
36. Ryder JW, Bassel-Duby R, Olson EN & Zierath JR (2003). Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J Biol Chem 278, 44298-44304.
37. Shimabukuro M, Zhou Y-T, Levi M & Unger RH (1998). Fatty acid-induced β cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci U S A 95, 2498-2502.
38. Sinha S, Perdomo G, Brown NF & O'Doherty RM (2004). Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor κB. J Biol Chem 279, 41294-41301.
39. Sparangna G & Hickson-bick D (2000). A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 279, H2124-H2132.
40. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD & Glass DJ (2004). The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14, 395-403.
41. Summers SA (2006). Ceramides in insulin resistance and lipotoxicity. Progr Lipid Res 45, 42-72.
42. Turpin SM, Lancaster GI, Darby I, Febbraio MA & Watt MJ (2006). Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol Endocrinol Metab 291, E1341-1350.
43. Unger RH (2003). Minireview: WeapTns of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144, 5159-5165.
44. Unger RH, Zhou YT & Orci L (1999). Regulation of fatty acid homeostasis in cells: Novel role of leptin. Proc Natl Acad Sci U S A 96, 2327-2332.
45. Uysal KT, Wiesbrock SM, Marino MW & Hotamisligil GS (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614.
46. Van Der Vusse G & Reneman R (1996). Lipid metabolism in muscle. In Handbook of Physiology: Section 12, Exercise: Regulation and Integration of Multiple Systems, ed. Rowell LB & Shepherd JT, pp. 952-994. Oxford University Press, New York.
47. Warmington S, Tolan R & McBennett S (2000). Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse. Int J Obes Relat Metab Disord 24, 1040-1050.
48. Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, Carling D, Kemp BE, Febbraio MA & Steinberg GR (2006a). CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 12, 541-548.
49. Watt MJ, Hevener A, Lancaster GI & Febbraio MA (2006b). Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. Endocrinology 147, 2077-2085.
50. Wei Y, Wang D, Topczewski F & Pagliassotti MJ (2006). Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291, E275-281.
51. Wellen KE & Hotamisligil GS (2005). Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119.
52. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH & Goldberg AL (2007). FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metabolism 6, 472-483.